Bristol Myers Squibb Receives European Commission Approval for Abecma , the First Anti-BCMA CAR T Cell Therapy for Relapsed and Refractory Multiple Myeloma Biotech Investing
New England Journal of Medicine Publishes 12-Week Results from Study Evaluating Atogepant for the Preventive Treatment of Migraine Biotech Investing
CORRECTION FROM SOURCE: BTV Examines the Rapidly Expanding Psychedelics Market Cannabis Investing News
EMA Validates Bristol Myers Squibb's Applications for Opdivo + Yervoy and Opdivo + Chemotherapy as First-Line Treatments for Unresectable Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma Biotech Investing
Aurinia Acquires Novel Pipeline Assets Targeting Autoimmune and Kidney-related Diseases Biotech Investing
Pfizer and BioNTech Announce Submission of Initial Data to U.S. FDA to Support Booster Dose of COVID-19 Vaccine Pharmaceutical Investing
Abbott's Amplatzer Amulet Device Approved by FDA to Treat People With Atrial Fibrillation at Risk of Stroke Medical Device Investing
FDA Approves Merck's Hypoxia-Inducible Factor-2 Alpha Inhibitor WELIREG for the Treatment of Patients With Certain Types of Von Hippel-Lindau Disease-Associated Tumors Pharmaceutical Investing
Merck Canada Initiates Rolling Submission to Health Canada for Molnupiravir, an Investigational Oral Therapeutic Agent for the Treatment of COVID-19 Pharmaceutical Investing
